| Dr Thomas C Yee, MD | |
|
1921 Realeza Ct, Ste. 200, Las Vegas, NV 89102-2062 | |
| (702) 562-3590 | |
| (702) 252-8826 |
| Full Name | Dr Thomas C Yee |
|---|---|
| Gender | Male |
| Speciality | Pain Management |
| Experience | 35 Years |
| Location | 1921 Realeza Ct, Las Vegas, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013980580 | NPI | - | NPPES |
| 002019428 | Medicaid | NV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 6769 (Nevada) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Desert Regional Medical Center | Palm springs, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Interventional Pain Medical Group | 0446294722 | 2 |
| Coachella Valley Anesthesia A Professional Corporation | 5698131969 | 67 |
| Dhp Anesthesia Medical Group Inc | 7113176421 | 22 |
News Archive
A study from the Journal of the American College of Nutrition (JACN) discusses fluid intake adequacy in detail and a simple tool is reviewed that may help healthy, active, low-risk populations answer the question, "Am I drinking enough?" The article "Am I Drinking Enough? Yes, No, and Maybe" by Samuel N. Cheuvront PhD, RD and Robert W. Kenefick PhD is made available with Free Access in JACN Issue 35(2) 2016, the official publication of the American College of Nutrition.
LecTec Corporation announced that in the patent infringement litigation entitled LecTec Corporation v. Chattem, Inc. et al. the parties met with the appointed judge for the United States District Court for the Eastern District of Texas. LecTec was informed at such hearing that due to a pending, unrelated, criminal matter, the trial date would be postponed from January 4, 2011 to Monday January 10, 2011.
Post-traumatic osteoarthritis is a musculoskeletal disorder shadowing especially the life of young and active population.
Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved CYRAMZA (ramucirumab) in combination with paclitaxel (a type of chemotherapy) as a treatment for people with advanced or metastatic gastric (stomach) or gastroesophageal junction (GEJ) adenocarcinoma whose cancer has progressed on or after prior fluoropyrimidine- or platinum-containing chemotherapy.
› Verified 3 days ago
| Entity Name | Interventional Pain Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932207248 PECOS PAC ID: 0446294722 Enrollment ID: O20050616001260 |
News Archive
A study from the Journal of the American College of Nutrition (JACN) discusses fluid intake adequacy in detail and a simple tool is reviewed that may help healthy, active, low-risk populations answer the question, "Am I drinking enough?" The article "Am I Drinking Enough? Yes, No, and Maybe" by Samuel N. Cheuvront PhD, RD and Robert W. Kenefick PhD is made available with Free Access in JACN Issue 35(2) 2016, the official publication of the American College of Nutrition.
LecTec Corporation announced that in the patent infringement litigation entitled LecTec Corporation v. Chattem, Inc. et al. the parties met with the appointed judge for the United States District Court for the Eastern District of Texas. LecTec was informed at such hearing that due to a pending, unrelated, criminal matter, the trial date would be postponed from January 4, 2011 to Monday January 10, 2011.
Post-traumatic osteoarthritis is a musculoskeletal disorder shadowing especially the life of young and active population.
Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved CYRAMZA (ramucirumab) in combination with paclitaxel (a type of chemotherapy) as a treatment for people with advanced or metastatic gastric (stomach) or gastroesophageal junction (GEJ) adenocarcinoma whose cancer has progressed on or after prior fluoropyrimidine- or platinum-containing chemotherapy.
› Verified 3 days ago
| Entity Name | Palm Springs Anesthesia Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083928501 PECOS PAC ID: 6406049592 Enrollment ID: O20101021000600 |
News Archive
A study from the Journal of the American College of Nutrition (JACN) discusses fluid intake adequacy in detail and a simple tool is reviewed that may help healthy, active, low-risk populations answer the question, "Am I drinking enough?" The article "Am I Drinking Enough? Yes, No, and Maybe" by Samuel N. Cheuvront PhD, RD and Robert W. Kenefick PhD is made available with Free Access in JACN Issue 35(2) 2016, the official publication of the American College of Nutrition.
LecTec Corporation announced that in the patent infringement litigation entitled LecTec Corporation v. Chattem, Inc. et al. the parties met with the appointed judge for the United States District Court for the Eastern District of Texas. LecTec was informed at such hearing that due to a pending, unrelated, criminal matter, the trial date would be postponed from January 4, 2011 to Monday January 10, 2011.
Post-traumatic osteoarthritis is a musculoskeletal disorder shadowing especially the life of young and active population.
Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved CYRAMZA (ramucirumab) in combination with paclitaxel (a type of chemotherapy) as a treatment for people with advanced or metastatic gastric (stomach) or gastroesophageal junction (GEJ) adenocarcinoma whose cancer has progressed on or after prior fluoropyrimidine- or platinum-containing chemotherapy.
› Verified 3 days ago
| Entity Name | Primary Anesthesia Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598053795 PECOS PAC ID: 8921272329 Enrollment ID: O20111121000946 |
News Archive
A study from the Journal of the American College of Nutrition (JACN) discusses fluid intake adequacy in detail and a simple tool is reviewed that may help healthy, active, low-risk populations answer the question, "Am I drinking enough?" The article "Am I Drinking Enough? Yes, No, and Maybe" by Samuel N. Cheuvront PhD, RD and Robert W. Kenefick PhD is made available with Free Access in JACN Issue 35(2) 2016, the official publication of the American College of Nutrition.
LecTec Corporation announced that in the patent infringement litigation entitled LecTec Corporation v. Chattem, Inc. et al. the parties met with the appointed judge for the United States District Court for the Eastern District of Texas. LecTec was informed at such hearing that due to a pending, unrelated, criminal matter, the trial date would be postponed from January 4, 2011 to Monday January 10, 2011.
Post-traumatic osteoarthritis is a musculoskeletal disorder shadowing especially the life of young and active population.
Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved CYRAMZA (ramucirumab) in combination with paclitaxel (a type of chemotherapy) as a treatment for people with advanced or metastatic gastric (stomach) or gastroesophageal junction (GEJ) adenocarcinoma whose cancer has progressed on or after prior fluoropyrimidine- or platinum-containing chemotherapy.
› Verified 3 days ago
| Entity Name | Orange Coast Anesthesia Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508138256 PECOS PAC ID: 2466613591 Enrollment ID: O20120417000047 |
News Archive
A study from the Journal of the American College of Nutrition (JACN) discusses fluid intake adequacy in detail and a simple tool is reviewed that may help healthy, active, low-risk populations answer the question, "Am I drinking enough?" The article "Am I Drinking Enough? Yes, No, and Maybe" by Samuel N. Cheuvront PhD, RD and Robert W. Kenefick PhD is made available with Free Access in JACN Issue 35(2) 2016, the official publication of the American College of Nutrition.
LecTec Corporation announced that in the patent infringement litigation entitled LecTec Corporation v. Chattem, Inc. et al. the parties met with the appointed judge for the United States District Court for the Eastern District of Texas. LecTec was informed at such hearing that due to a pending, unrelated, criminal matter, the trial date would be postponed from January 4, 2011 to Monday January 10, 2011.
Post-traumatic osteoarthritis is a musculoskeletal disorder shadowing especially the life of young and active population.
Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved CYRAMZA (ramucirumab) in combination with paclitaxel (a type of chemotherapy) as a treatment for people with advanced or metastatic gastric (stomach) or gastroesophageal junction (GEJ) adenocarcinoma whose cancer has progressed on or after prior fluoropyrimidine- or platinum-containing chemotherapy.
› Verified 3 days ago
| Entity Name | Dhp Anesthesia Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093078974 PECOS PAC ID: 7113176421 Enrollment ID: O20121002000299 |
News Archive
A study from the Journal of the American College of Nutrition (JACN) discusses fluid intake adequacy in detail and a simple tool is reviewed that may help healthy, active, low-risk populations answer the question, "Am I drinking enough?" The article "Am I Drinking Enough? Yes, No, and Maybe" by Samuel N. Cheuvront PhD, RD and Robert W. Kenefick PhD is made available with Free Access in JACN Issue 35(2) 2016, the official publication of the American College of Nutrition.
LecTec Corporation announced that in the patent infringement litigation entitled LecTec Corporation v. Chattem, Inc. et al. the parties met with the appointed judge for the United States District Court for the Eastern District of Texas. LecTec was informed at such hearing that due to a pending, unrelated, criminal matter, the trial date would be postponed from January 4, 2011 to Monday January 10, 2011.
Post-traumatic osteoarthritis is a musculoskeletal disorder shadowing especially the life of young and active population.
Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved CYRAMZA (ramucirumab) in combination with paclitaxel (a type of chemotherapy) as a treatment for people with advanced or metastatic gastric (stomach) or gastroesophageal junction (GEJ) adenocarcinoma whose cancer has progressed on or after prior fluoropyrimidine- or platinum-containing chemotherapy.
› Verified 3 days ago
| Entity Name | Premiercare Anesthesia Fountain Valley Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831536531 PECOS PAC ID: 5698903003 Enrollment ID: O20140110000426 |
News Archive
A study from the Journal of the American College of Nutrition (JACN) discusses fluid intake adequacy in detail and a simple tool is reviewed that may help healthy, active, low-risk populations answer the question, "Am I drinking enough?" The article "Am I Drinking Enough? Yes, No, and Maybe" by Samuel N. Cheuvront PhD, RD and Robert W. Kenefick PhD is made available with Free Access in JACN Issue 35(2) 2016, the official publication of the American College of Nutrition.
LecTec Corporation announced that in the patent infringement litigation entitled LecTec Corporation v. Chattem, Inc. et al. the parties met with the appointed judge for the United States District Court for the Eastern District of Texas. LecTec was informed at such hearing that due to a pending, unrelated, criminal matter, the trial date would be postponed from January 4, 2011 to Monday January 10, 2011.
Post-traumatic osteoarthritis is a musculoskeletal disorder shadowing especially the life of young and active population.
Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved CYRAMZA (ramucirumab) in combination with paclitaxel (a type of chemotherapy) as a treatment for people with advanced or metastatic gastric (stomach) or gastroesophageal junction (GEJ) adenocarcinoma whose cancer has progressed on or after prior fluoropyrimidine- or platinum-containing chemotherapy.
› Verified 3 days ago
| Entity Name | Talbert Anesthesia Group Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144626714 PECOS PAC ID: 6406171461 Enrollment ID: O20150213001921 |
News Archive
A study from the Journal of the American College of Nutrition (JACN) discusses fluid intake adequacy in detail and a simple tool is reviewed that may help healthy, active, low-risk populations answer the question, "Am I drinking enough?" The article "Am I Drinking Enough? Yes, No, and Maybe" by Samuel N. Cheuvront PhD, RD and Robert W. Kenefick PhD is made available with Free Access in JACN Issue 35(2) 2016, the official publication of the American College of Nutrition.
LecTec Corporation announced that in the patent infringement litigation entitled LecTec Corporation v. Chattem, Inc. et al. the parties met with the appointed judge for the United States District Court for the Eastern District of Texas. LecTec was informed at such hearing that due to a pending, unrelated, criminal matter, the trial date would be postponed from January 4, 2011 to Monday January 10, 2011.
Post-traumatic osteoarthritis is a musculoskeletal disorder shadowing especially the life of young and active population.
Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved CYRAMZA (ramucirumab) in combination with paclitaxel (a type of chemotherapy) as a treatment for people with advanced or metastatic gastric (stomach) or gastroesophageal junction (GEJ) adenocarcinoma whose cancer has progressed on or after prior fluoropyrimidine- or platinum-containing chemotherapy.
› Verified 3 days ago
| Entity Name | Landmark Anesthesia Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770035024 PECOS PAC ID: 5698055804 Enrollment ID: O20161206000144 |
News Archive
A study from the Journal of the American College of Nutrition (JACN) discusses fluid intake adequacy in detail and a simple tool is reviewed that may help healthy, active, low-risk populations answer the question, "Am I drinking enough?" The article "Am I Drinking Enough? Yes, No, and Maybe" by Samuel N. Cheuvront PhD, RD and Robert W. Kenefick PhD is made available with Free Access in JACN Issue 35(2) 2016, the official publication of the American College of Nutrition.
LecTec Corporation announced that in the patent infringement litigation entitled LecTec Corporation v. Chattem, Inc. et al. the parties met with the appointed judge for the United States District Court for the Eastern District of Texas. LecTec was informed at such hearing that due to a pending, unrelated, criminal matter, the trial date would be postponed from January 4, 2011 to Monday January 10, 2011.
Post-traumatic osteoarthritis is a musculoskeletal disorder shadowing especially the life of young and active population.
Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved CYRAMZA (ramucirumab) in combination with paclitaxel (a type of chemotherapy) as a treatment for people with advanced or metastatic gastric (stomach) or gastroesophageal junction (GEJ) adenocarcinoma whose cancer has progressed on or after prior fluoropyrimidine- or platinum-containing chemotherapy.
› Verified 3 days ago
| Entity Name | Loma Linda Anesthesia Services A Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245846146 PECOS PAC ID: 4385056548 Enrollment ID: O20201211000112 |
News Archive
A study from the Journal of the American College of Nutrition (JACN) discusses fluid intake adequacy in detail and a simple tool is reviewed that may help healthy, active, low-risk populations answer the question, "Am I drinking enough?" The article "Am I Drinking Enough? Yes, No, and Maybe" by Samuel N. Cheuvront PhD, RD and Robert W. Kenefick PhD is made available with Free Access in JACN Issue 35(2) 2016, the official publication of the American College of Nutrition.
LecTec Corporation announced that in the patent infringement litigation entitled LecTec Corporation v. Chattem, Inc. et al. the parties met with the appointed judge for the United States District Court for the Eastern District of Texas. LecTec was informed at such hearing that due to a pending, unrelated, criminal matter, the trial date would be postponed from January 4, 2011 to Monday January 10, 2011.
Post-traumatic osteoarthritis is a musculoskeletal disorder shadowing especially the life of young and active population.
Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved CYRAMZA (ramucirumab) in combination with paclitaxel (a type of chemotherapy) as a treatment for people with advanced or metastatic gastric (stomach) or gastroesophageal junction (GEJ) adenocarcinoma whose cancer has progressed on or after prior fluoropyrimidine- or platinum-containing chemotherapy.
› Verified 3 days ago
| Entity Name | Coachella Valley Anesthesia A Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013662048 PECOS PAC ID: 5698131969 Enrollment ID: O20230512000330 |
News Archive
A study from the Journal of the American College of Nutrition (JACN) discusses fluid intake adequacy in detail and a simple tool is reviewed that may help healthy, active, low-risk populations answer the question, "Am I drinking enough?" The article "Am I Drinking Enough? Yes, No, and Maybe" by Samuel N. Cheuvront PhD, RD and Robert W. Kenefick PhD is made available with Free Access in JACN Issue 35(2) 2016, the official publication of the American College of Nutrition.
LecTec Corporation announced that in the patent infringement litigation entitled LecTec Corporation v. Chattem, Inc. et al. the parties met with the appointed judge for the United States District Court for the Eastern District of Texas. LecTec was informed at such hearing that due to a pending, unrelated, criminal matter, the trial date would be postponed from January 4, 2011 to Monday January 10, 2011.
Post-traumatic osteoarthritis is a musculoskeletal disorder shadowing especially the life of young and active population.
Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved CYRAMZA (ramucirumab) in combination with paclitaxel (a type of chemotherapy) as a treatment for people with advanced or metastatic gastric (stomach) or gastroesophageal junction (GEJ) adenocarcinoma whose cancer has progressed on or after prior fluoropyrimidine- or platinum-containing chemotherapy.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas C Yee, MD 1921 Realeza Court, Las Vegas, NV 89102-6017 Ph: (702) 813-3888 | Dr Thomas C Yee, MD 1921 Realeza Ct, Ste. 200, Las Vegas, NV 89102-2062 Ph: (702) 562-3590 |
News Archive
A study from the Journal of the American College of Nutrition (JACN) discusses fluid intake adequacy in detail and a simple tool is reviewed that may help healthy, active, low-risk populations answer the question, "Am I drinking enough?" The article "Am I Drinking Enough? Yes, No, and Maybe" by Samuel N. Cheuvront PhD, RD and Robert W. Kenefick PhD is made available with Free Access in JACN Issue 35(2) 2016, the official publication of the American College of Nutrition.
LecTec Corporation announced that in the patent infringement litigation entitled LecTec Corporation v. Chattem, Inc. et al. the parties met with the appointed judge for the United States District Court for the Eastern District of Texas. LecTec was informed at such hearing that due to a pending, unrelated, criminal matter, the trial date would be postponed from January 4, 2011 to Monday January 10, 2011.
Post-traumatic osteoarthritis is a musculoskeletal disorder shadowing especially the life of young and active population.
Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved CYRAMZA (ramucirumab) in combination with paclitaxel (a type of chemotherapy) as a treatment for people with advanced or metastatic gastric (stomach) or gastroesophageal junction (GEJ) adenocarcinoma whose cancer has progressed on or after prior fluoropyrimidine- or platinum-containing chemotherapy.
› Verified 3 days ago
Mark Livingston, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 9127 W Russell Rd Ste 110, Las Vegas, NV 89148 Phone: 702-878-0070 Fax: 702-209-2064 | |
Dr. Charles Minh, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 205 Elder View Dr, Las Vegas, NV 89138 Phone: 702-907-6464 | |
Ryan Nimer, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 7160 Rafael Rivera Way Ste 210, Las Vegas, NV 89113 Phone: 702-878-0070 Fax: 702-209-2064 | |
Liam Kelly Sullivan, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 7160 Rafael Rivera Way Ste 210, Las Vegas, NV 89113 Phone: 702-878-0070 Fax: 702-805-0307 | |
James Murphy, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 2635 Box Canyon Dr, Las Vegas, NV 89128 Phone: 702-386-4700 Fax: 702-386-4701 | |
Scott Young, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 7250 Peak Dr Ste 100, Las Vegas, NV 89128 Phone: 702-386-4700 Fax: 702-386-4701 | |
Dr. Derek Michael Goffstein, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 7160 Rafael Rivera Way Ste 210, Las Vegas, NV 89113 Phone: 702-878-0070 Fax: 702-805-0307 |